These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 32797054)
1. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. Sabatino J; De Rosa S; Di Salvo G; Indolfi C PLoS One; 2020; 15(8):e0237131. PubMed ID: 32797054 [TBL] [Abstract][Full Text] [Related]
2. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis. Khan MMA; Khan MN; Mustagir MG; Rana J; Islam MS; Kabir MI J Glob Health; 2020 Dec; 10(2):020503. PubMed ID: 33110586 [TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far? Kurdi A; Abutheraa N; Akil L; Godman B Pharmacol Res Perspect; 2020 Dec; 8(6):e00666. PubMed ID: 33084232 [TBL] [Abstract][Full Text] [Related]
4. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716 [TBL] [Abstract][Full Text] [Related]
5. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. Roncon L; Zuin M; Rigatelli G; Zuliani G J Clin Virol; 2020 Jun; 127():104354. PubMed ID: 32305882 [TBL] [Abstract][Full Text] [Related]
6. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York. Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. Xiong S; Liu L; Lin F; Shi J; Han L; Liu H; He L; Jiang Q; Wang Z; Fu W; Li Z; Lu Q; Chen Z; Ding S BMC Infect Dis; 2020 Oct; 20(1):787. PubMed ID: 33092539 [TBL] [Abstract][Full Text] [Related]
8. Coronavirus (SARS-CoV-2) and the risk of obesity for critically illness and ICU admitted: Meta-analysis of the epidemiological evidence. Sales-Peres SHC; de Azevedo-Silva LJ; Bonato RCS; Sales-Peres MC; Pinto ACDS; Santiago Junior JF Obes Res Clin Pract; 2020; 14(5):389-397. PubMed ID: 32773297 [TBL] [Abstract][Full Text] [Related]
9. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. Meng Y; Lu W; Guo E; Liu J; Yang B; Wu P; Lin S; Peng T; Fu Y; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Lu F; Wu X; You L; Ma D; Sun C; Wu P; Chen G J Hematol Oncol; 2020 Jun; 13(1):75. PubMed ID: 32522278 [TBL] [Abstract][Full Text] [Related]
10. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT. Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330 [TBL] [Abstract][Full Text] [Related]
11. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. Pranata R; Huang I; Lim MA; Wahjoepramono EJ; July J J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104949. PubMed ID: 32410807 [TBL] [Abstract][Full Text] [Related]
12. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System. Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis. Javanmardi F; Keshavarzi A; Akbari A; Emami A; Pirbonyeh N PLoS One; 2020; 15(10):e0241265. PubMed ID: 33095835 [TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
15. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis. de Azambuja E; Brandão M; Wildiers H; Laenen A; Aspeslagh S; Fontaine C; Collignon J; Lybaert W; Verheezen J; Rutten A; Vuylsteke P; Goeminne JC; Demey W; Van Beckhoven D; Deblonde J; Rottey S; Geukens T; Punie K; ; Bafort K; Belkhir L; Bossuyt N; Colombie V; Daubresse C; Dauby N; De Munter P; Delmarcelle D; Delvallee M; Demeester R; Delefortrie Q; Dugernier T; Holemans X; Louviaux I; Machurot P; Minette P; Mokrane S; Nachtergal C; Noirhomme S; Piérard D; Rossi C; Schirvel C; Sermijn E; Staelens F; Triest F; Van Beckhoven D; Van Goethem N; Van Praet J; Vanhoenacker A; Verstraete R; Willems E; Wyndham-Thomas C ESMO Open; 2020 Sep; 5(5):e000947. PubMed ID: 32978251 [TBL] [Abstract][Full Text] [Related]
16. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Jutzeler CR; Bourguignon L; Weis CV; Tong B; Wong C; Rieck B; Pargger H; Tschudin-Sutter S; Egli A; Borgwardt K; Walter M Travel Med Infect Dis; 2020; 37():101825. PubMed ID: 32763496 [TBL] [Abstract][Full Text] [Related]
17. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. Pranata R; Huang I; Lim MA; Wahjoepramono EJ; July J J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104949. PubMed ID: 32927523 [TBL] [Abstract][Full Text] [Related]
18. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868 [TBL] [Abstract][Full Text] [Related]
19. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. Nikpouraghdam M; Jalali Farahani A; Alishiri G; Heydari S; Ebrahimnia M; Samadinia H; Sepandi M; Jafari NJ; Izadi M; Qazvini A; Dorostkar R; Tat M; Shahriary A; Farnoosh G; Hosseini Zijoud SR; Taghdir M; Alimohamadi Y; Abbaszadeh S; Gouvarchin Ghaleh HE; Bagheri M J Clin Virol; 2020 Jun; 127():104378. PubMed ID: 32353762 [TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]